Retroviral Gag Trafficking, Env Incorporation, and Virus Assembly
逆转录病毒堵嘴贩运、Env 合并和病毒组装
基本信息
- 批准号:7733213
- 负责人:
- 金额:$ 46.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Adaptor Signaling ProteinAddressCell membraneCell surfaceCellsCytoplasmic TailDependenceDestinationsEquine Infectious AnemiaEquine Infectious Anemia VirusEquine LentivirusesFamilyFamily FelidaeFeline Immunodeficiency VirusGaggingGlycoproteinsGoalsHIV Drug Resistance ProgramHIV-1Imaging TechniquesImmunologic Deficiency SyndromesLifeLipidsMembrane MicrodomainsMolecularPhosphatidylinositolsPlayPoint MutationProcessReportingRoleSiteSite VisitSubfamily lentivirinaeViralVirionVirusVirus Assemblybasecell typecellular imagingmembernonhuman primatetrafficking
项目摘要
In most cell types, HIV-1 assembly occurs predominantly on the plasma membrane; however, the itinerary that the Gag precursor follows to reach its destination in the cell remains ill-defined. It has been suggested that even in cell types in which assembly and budding occur predominantly at the plasma membrane, Gag traffics through an endosomal or endocytic compartment before reaching the cell surface. We and others have demonstrated that the matrix (MA) domain of Gag regulates the site of virus assembly, and we discovered recently that a member of the phosphoinositide family of lipids, phosphatidylinositol (4,5) bisphosphate [PI(4,5)P2], serves an important function in directing Pr55Gag to the plasma membrane. We are actively engaged in studies that seek to define the subcellular site of HIV-1 assembly in physiologically relevant cell types, and to elucidate further the cellular machinery involved in HIV-1 Gag trafficking. This effort makes use of live-cell imaging techniques recently developed in the VCIS, and is also being extended to the non-human primate lentiviruses equine infectious anemia virus (EIAV) and feline immunodeficiency virus (FIV). The viral envelope (Env) glycoproteins are incorporated into virions during the assembly process. We have shown that point mutations in the MA domain of Gag block Env incorporation, and demonstrated that the long gp41 cytoplasmic tail plays a cell type-dependent role in Env incorporation. Despite the evidence for a direct interaction between MA and the gp41 cytoplasmic tail, the molecular mechanism by which Env is incorporated, the subcellular site of initial Gag-Env contact, and the basis for cell type dependence of cytoplasmic tail function remain to be defined. We will address these issues; specifically, we will evaluate the role of cellular factors and lipid rafts in Env incorporation. [Corresponds to Freed Project 1 in the April 2007 site visit report of the HIV Drug Resistance Program]
在大多数细胞类型中,HIV-1的组装主要发生在质膜上;然而,Gag前体在细胞内到达目的地的路线仍然不明确。有研究表明,即使在组装和出芽主要发生在质膜上的细胞类型中,Gag在到达细胞表面之前也会通过内体或内胞室进行运输。我们和其他人已经证明Gag的基质(MA)结构域调节病毒组装位点,并且我们最近发现磷脂肌醇脂类家族的成员磷脂酰肌醇(4,5)二磷酸[PI(4,5)P2]在将Pr55Gag引导到质膜中起重要作用。我们正积极参与研究,试图在生理相关的细胞类型中定义HIV-1组装的亚细胞位点,并进一步阐明参与HIV-1 Gag运输的细胞机制。这项工作利用了VCIS最近开发的活细胞成像技术,并正在扩展到非人灵长类慢病毒马传染性贫血病毒(EIAV)和猫免疫缺陷病毒(FIV)。病毒包膜(Env)糖蛋白在组装过程中被整合到病毒粒子中。我们已经证明Gag的MA结构域的点突变阻断Env的结合,并证明长gp41细胞质尾部在Env的结合中起细胞类型依赖的作用。尽管有证据表明MA与gp41细胞质尾部之间存在直接相互作用,但Env结合的分子机制、Gag-Env初始接触的亚细胞位点以及细胞质尾部功能的细胞类型依赖性的基础仍有待明确。我们将解决这些问题;具体来说,我们将评估细胞因子和脂筏在Env掺入中的作用。[对应于2007年4月艾滋病毒耐药性计划实地考察报告中的自由项目1]
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Photoinduced reactivity of the HIV-1 envelope glycoprotein with a membrane-embedded probe reveals insertion of portions of the HIV-1 Gp41 cytoplasmic tail into the viral membrane.
HIV-1 包膜糖蛋白与膜嵌入探针的光诱导反应揭示了 HIV-1 Gp41 胞质尾部的部分插入到病毒膜中。
- DOI:10.1021/bi701920f
- 发表时间:2008
- 期刊:
- 影响因子:2.9
- 作者:Viard,Mathias;Ablan,SherimayD;Zhou,Ming;Veenstra,TimothyD;Freed,EricO;Raviv,Yossef;Blumenthal,Robert
- 通讯作者:Blumenthal,Robert
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
eric freed其他文献
eric freed的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('eric freed', 18)}}的其他基金
Antagonism of Coronavirus Spike Proteins by Cellular Host Factors
细胞宿主因子对冠状病毒刺突蛋白的拮抗作用
- 批准号:
10487091 - 财政年份:
- 资助金额:
$ 46.06万 - 项目类别:
Retroviral Gag Trafficking, Env Incorporation, and Virus Assembly
逆转录病毒堵嘴贩运、Env 合并和病毒组装
- 批准号:
8349150 - 财政年份:
- 资助金额:
$ 46.06万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 46.06万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 46.06万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 46.06万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 46.06万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 46.06万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 46.06万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 46.06万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 46.06万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 46.06万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 46.06万 - 项目类别:
Research Grant